AI Article Synopsis

  • Take-home naloxone (THN) interventions effectively prevent overdose deaths, but their use in Australia is still low; this project aimed to create a model (ORTHN) specifically for opioid users attending treatment and health services.* -
  • The ORTHN model involved training clients and providing naloxone via a collaborative effort from service providers and health workers; it was implemented in over 15 services in New South Wales, with evaluations done on participants' knowledge and experiences before and after the intervention.* -
  • Results showed positive outcomes with improved attitudes toward overdose response, a significant number of participants successfully reversing overdoses, and an indication of willingness to access THN services, suggesting that the ORTHN model could effectively promote

Article Abstract

Introduction And Designs: Take-home naloxone (THN) interventions are an effective response to preventing overdose deaths, however uptake across Australia remains limited. This project designed, implemented and evaluated a model of care targeting opioid users attending alcohol and other drug (AOD) treatment, needle and syringe programs (NSP) and related health services targeting people who inject drugs.

Design And Methods: Service providers, consumers and regulators collaboratively designed a THN brief intervention (ORTHN, Overdose Response with Take-Home Naloxone) involving client education and supply of naloxone in pre-filled syringes, delivered by nursing, allied health and NSP workers. ORTHN interventions were implemented in over 15 services across New South Wales, Australia. The evaluation included client knowledge, attitudes, substance use and overdose experiences immediately before and 3 months after ORTHN intervention in a subsample of participants.

Results: Six hundred and sixteen interventions were delivered, with 145 participants recruited to the research subsample, of whom 95 completed the three-month follow up. Overdose-related attitudes amongst participants improved following ORTHN, with no evidence of increased substance use or failure to implement other 'first responses' (e.g. calling an ambulance). Nine participants (10%) reversed an overdose using THN in the follow-up period. Participants identified a willingness to access THN from a range of services. While a minority (16%) indicated they were unwilling to pay for THN, the median price that participants were willing to pay was $AUD20 (IQR $10.40).

Discussion And Conclusions: The ORTHN model of care for THN appears an effective way to disseminate THN to people who use opioids attending AOD, NSP and related health-care settings.

Download full-text PDF

Source
http://dx.doi.org/10.1111/dar.13015DOI Listing

Publication Analysis

Top Keywords

take-home naloxone
12
model care
12
overdose response
8
response take-home
8
thn
7
overdose
5
orthn
5
participants
5
designing implementing
4
implementing evaluating
4

Similar Publications

Objectives: Opioid-associated fatal and non-fatal overdose rates continue to rise. Prehospital overdose education and naloxone distribution (OEND) programs are attractive harm-reduction strategies, as patients who are not transported by EMS after receiving naloxone have limited access to other interventions. This narrative summary describes our experiences with prehospital implementation of evidence-based OEND practices across Ohio as part of the HEALing Communities Study (HCS).

View Article and Find Full Text PDF

Objectives: Take home naloxone kits can reduce mortality, but we know little about how they are perceived by people with lived experience of opioid use. Provision of naloxone in the community has been shown to significantly reduce mortality from opioid overdose. Currently, this is predominantly through drug treatment support services but expanding provision through other services might be effective in increasing kit take-up and mortality reduction.

View Article and Find Full Text PDF

Agent-Based Model of Combined Community- and Jail-Based Take-Home Naloxone Distribution.

JAMA Netw Open

December 2024

Decision and Infrastructure Sciences Division, Argonne National Laboratory, Lemont, Illinois.

Importance: Opioid-related overdose accounts for almost 80 000 deaths annually across the US. People who use drugs leaving jails are at particularly high risk for opioid-related overdose and may benefit from take-home naloxone (THN) distribution.

Objective: To estimate the population impact of THN distribution at jail release to reverse opioid-related overdose among people with opioid use disorders.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of opioid agonist therapy (OAT) on methamphetamine and amphetamine use among individuals with opioid use disorder (OUD) in Canada, comparing buprenorphine/naloxone and methadone.
  • Conducted over 24 weeks, data from a pan-Canadian trial highlighted that both treatments showed no significant effect on reducing methamphetamine/amphetamine use, as assessed through drug testing and self-reporting.
  • Despite methamphetamine/amphetamine use being prevalent among participants, results indicated that neither treatment method led to notable changes in their usage patterns throughout the study period.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!